Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer

A cell population dynamics model

Jennifer Pasquier, Pierre Magal, Céline Boulangé-Lecomte, Glenn Webb, Frank Le Foll

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: Cancer is a proliferation disease affecting a genetically unstable cell population, in which molecular alterations can be somatically inherited by genetic, epigenetic or extragenetic transmission processes, leading to a cooperation of neoplastic cells within tumoural tissue. The efflux protein P-glycoprotein (P-gp) is overexpressed in many cancer cells and has known capacity to confer multidrug resistance to cytotoxic therapies. Recently, cell-to-cell P-gp transfers have been shown. Herein, we combine experimental evidence and a mathematical model to examine the consequences of an intercellular P-gp trafficking in the extragenetic transfer of multidrug resistance from resistant to sensitive cell subpopulations.Methodology and Principal Findings: We report cell-to-cell transfers of functional P-gp in co-cultures of a P-gp overexpressing human breast cancer MCF-7 cell variant, selected for its resistance towards doxorubicin, with the parental sensitive cell line. We found that P-gp as well as efflux activity distribution are progressively reorganized over time in co-cultures analyzed by flow cytometry. A mathematical model based on a Boltzmann type integro-partial differential equation structured by a continuum variable corresponding to P-gp activity describes the cell populations in co-culture. The mathematical model elucidates the population elements in the experimental data, specifically, the initial proportions, the proliferative growth rates, and the transfer rates of P-gp in the sensitive and resistant subpopulations.Conclusions: We confirmed cell-to-cell transfer of functional P-gp. The transfer process depends on the gradient of P-gp expression in the donor-recipient cell interactions, as they evolve over time. Extragenetically acquired drug resistance is an additional aptitude of neoplastic cells which has implications in the diagnostic value of P-gp expression and in the design of chemotherapy regimens.Reviewers: This article was reviewed by Leonid Hanin, Anna Marciniak-Czochra and Marek Kimmel.

Original languageEnglish
Article number5
JournalBiology Direct
Volume6
DOIs
Publication statusPublished - 26 Jan 2011
Externally publishedYes

Fingerprint

Population dynamics
Glycoproteins
Glycoprotein
multiple drug resistance
Cell Population
Population Dynamics
Multiple Drug Resistance
P-Glycoprotein
Population Model
Breast Cancer
dynamic models
breast neoplasms
Dynamic models
cancer
Dynamic Model
population dynamics
Cells
Breast Neoplasms
subpopulation
Cell

ASJC Scopus subject areas

  • Immunology
  • Ecology, Evolution, Behavior and Systematics
  • Modelling and Simulation
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Applied Mathematics

Cite this

Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer : A cell population dynamics model. / Pasquier, Jennifer; Magal, Pierre; Boulangé-Lecomte, Céline; Webb, Glenn; Le Foll, Frank.

In: Biology Direct, Vol. 6, 5, 26.01.2011.

Research output: Contribution to journalArticle

@article{2eb336f2821b48069fd1da5419ccc4b4,
title = "Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: A cell population dynamics model",
abstract = "Background: Cancer is a proliferation disease affecting a genetically unstable cell population, in which molecular alterations can be somatically inherited by genetic, epigenetic or extragenetic transmission processes, leading to a cooperation of neoplastic cells within tumoural tissue. The efflux protein P-glycoprotein (P-gp) is overexpressed in many cancer cells and has known capacity to confer multidrug resistance to cytotoxic therapies. Recently, cell-to-cell P-gp transfers have been shown. Herein, we combine experimental evidence and a mathematical model to examine the consequences of an intercellular P-gp trafficking in the extragenetic transfer of multidrug resistance from resistant to sensitive cell subpopulations.Methodology and Principal Findings: We report cell-to-cell transfers of functional P-gp in co-cultures of a P-gp overexpressing human breast cancer MCF-7 cell variant, selected for its resistance towards doxorubicin, with the parental sensitive cell line. We found that P-gp as well as efflux activity distribution are progressively reorganized over time in co-cultures analyzed by flow cytometry. A mathematical model based on a Boltzmann type integro-partial differential equation structured by a continuum variable corresponding to P-gp activity describes the cell populations in co-culture. The mathematical model elucidates the population elements in the experimental data, specifically, the initial proportions, the proliferative growth rates, and the transfer rates of P-gp in the sensitive and resistant subpopulations.Conclusions: We confirmed cell-to-cell transfer of functional P-gp. The transfer process depends on the gradient of P-gp expression in the donor-recipient cell interactions, as they evolve over time. Extragenetically acquired drug resistance is an additional aptitude of neoplastic cells which has implications in the diagnostic value of P-gp expression and in the design of chemotherapy regimens.Reviewers: This article was reviewed by Leonid Hanin, Anna Marciniak-Czochra and Marek Kimmel.",
author = "Jennifer Pasquier and Pierre Magal and C{\'e}line Boulang{\'e}-Lecomte and Glenn Webb and {Le Foll}, Frank",
year = "2011",
month = "1",
day = "26",
doi = "10.1186/1745-6150-6-5",
language = "English",
volume = "6",
journal = "Biology Direct",
issn = "1745-6150",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer

T2 - A cell population dynamics model

AU - Pasquier, Jennifer

AU - Magal, Pierre

AU - Boulangé-Lecomte, Céline

AU - Webb, Glenn

AU - Le Foll, Frank

PY - 2011/1/26

Y1 - 2011/1/26

N2 - Background: Cancer is a proliferation disease affecting a genetically unstable cell population, in which molecular alterations can be somatically inherited by genetic, epigenetic or extragenetic transmission processes, leading to a cooperation of neoplastic cells within tumoural tissue. The efflux protein P-glycoprotein (P-gp) is overexpressed in many cancer cells and has known capacity to confer multidrug resistance to cytotoxic therapies. Recently, cell-to-cell P-gp transfers have been shown. Herein, we combine experimental evidence and a mathematical model to examine the consequences of an intercellular P-gp trafficking in the extragenetic transfer of multidrug resistance from resistant to sensitive cell subpopulations.Methodology and Principal Findings: We report cell-to-cell transfers of functional P-gp in co-cultures of a P-gp overexpressing human breast cancer MCF-7 cell variant, selected for its resistance towards doxorubicin, with the parental sensitive cell line. We found that P-gp as well as efflux activity distribution are progressively reorganized over time in co-cultures analyzed by flow cytometry. A mathematical model based on a Boltzmann type integro-partial differential equation structured by a continuum variable corresponding to P-gp activity describes the cell populations in co-culture. The mathematical model elucidates the population elements in the experimental data, specifically, the initial proportions, the proliferative growth rates, and the transfer rates of P-gp in the sensitive and resistant subpopulations.Conclusions: We confirmed cell-to-cell transfer of functional P-gp. The transfer process depends on the gradient of P-gp expression in the donor-recipient cell interactions, as they evolve over time. Extragenetically acquired drug resistance is an additional aptitude of neoplastic cells which has implications in the diagnostic value of P-gp expression and in the design of chemotherapy regimens.Reviewers: This article was reviewed by Leonid Hanin, Anna Marciniak-Czochra and Marek Kimmel.

AB - Background: Cancer is a proliferation disease affecting a genetically unstable cell population, in which molecular alterations can be somatically inherited by genetic, epigenetic or extragenetic transmission processes, leading to a cooperation of neoplastic cells within tumoural tissue. The efflux protein P-glycoprotein (P-gp) is overexpressed in many cancer cells and has known capacity to confer multidrug resistance to cytotoxic therapies. Recently, cell-to-cell P-gp transfers have been shown. Herein, we combine experimental evidence and a mathematical model to examine the consequences of an intercellular P-gp trafficking in the extragenetic transfer of multidrug resistance from resistant to sensitive cell subpopulations.Methodology and Principal Findings: We report cell-to-cell transfers of functional P-gp in co-cultures of a P-gp overexpressing human breast cancer MCF-7 cell variant, selected for its resistance towards doxorubicin, with the parental sensitive cell line. We found that P-gp as well as efflux activity distribution are progressively reorganized over time in co-cultures analyzed by flow cytometry. A mathematical model based on a Boltzmann type integro-partial differential equation structured by a continuum variable corresponding to P-gp activity describes the cell populations in co-culture. The mathematical model elucidates the population elements in the experimental data, specifically, the initial proportions, the proliferative growth rates, and the transfer rates of P-gp in the sensitive and resistant subpopulations.Conclusions: We confirmed cell-to-cell transfer of functional P-gp. The transfer process depends on the gradient of P-gp expression in the donor-recipient cell interactions, as they evolve over time. Extragenetically acquired drug resistance is an additional aptitude of neoplastic cells which has implications in the diagnostic value of P-gp expression and in the design of chemotherapy regimens.Reviewers: This article was reviewed by Leonid Hanin, Anna Marciniak-Czochra and Marek Kimmel.

UR - http://www.scopus.com/inward/record.url?scp=79251540574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251540574&partnerID=8YFLogxK

U2 - 10.1186/1745-6150-6-5

DO - 10.1186/1745-6150-6-5

M3 - Article

VL - 6

JO - Biology Direct

JF - Biology Direct

SN - 1745-6150

M1 - 5

ER -